ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 386 filers reported holding ENCOMPASS HEALTH CORP in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,078,444 | +2675.9% | 130,840 | +3555.8% | 0.01% | – |
| Q1 2022 | $255,000 | -94.8% | 3,579 | -94.6% | 0.00% | -100.0% |
| Q3 2021 | $4,935,000 | +23.1% | 65,766 | +28.0% | 0.01% | 0.0% |
| Q2 2021 | $4,009,000 | -30.6% | 51,376 | -27.1% | 0.01% | -47.6% |
| Q1 2021 | $5,773,000 | -55.7% | 70,483 | -55.3% | 0.02% | -59.6% |
| Q4 2020 | $13,026,000 | +826.5% | 157,532 | +628.0% | 0.05% | +766.7% |
| Q3 2020 | $1,406,000 | +379.9% | 21,639 | +357.5% | 0.01% | +500.0% |
| Q2 2020 | $293,000 | -69.2% | 4,730 | -68.2% | 0.00% | -80.0% |
| Q1 2020 | $951,000 | +1967.4% | 14,854 | +2123.7% | 0.01% | – |
| Q4 2019 | $46,000 | -93.3% | 668 | -93.8% | 0.00% | -100.0% |
| Q3 2019 | $686,000 | -34.9% | 10,847 | -34.7% | 0.00% | -40.0% |
| Q2 2019 | $1,053,000 | +27.9% | 16,613 | +57.3% | 0.01% | -16.7% |
| Q3 2018 | $823,000 | – | 10,558 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |